Lam Research (LRCX)

Lam’s June-ended fiscal fourth quarter brought stronger revenue, a wider operating margin and higher reported diluted earnings per share than the same fiscal quarter of the prior year. The business retained more operating profit from each dollar of sales.

The cash result was less convincing. For the reported quarter, operating cash flow declined against the same fiscal quarter of the prior year, even as earnings per share improved.

Lam Research makes equipment used to manufacture semiconductors.

We like Lam because it works at the precision heart of chipmaking. Its leadership in etch and strong position in deposition give it a powerful platform for helping customers build and shape intricate chip structures. The exciting opportunity is to carry that expertise into more of the manufacturing process, from dry photoresist technology to wafer-level packaging.

Lam earns revenue by supplying equipment and services to chipmakers, including TSMC, Samsung, Intel and Micron. Deposition builds material layers, while etch selectively removes material to create patterns. Its customer exposure leans toward memory manufacturers, making their investment decisions particularly important.

June-ended fiscal fourth-quarter revenue increased against both the preceding fiscal quarter and the same fiscal quarter of the prior year. The consolidated figures establish stronger sales, but they do not identify which products or customers contributed most.

The annual filing describes technologies that extend Lam’s reach across manufacturing steps. Dry photoresist technology connects pattern preparation with etch and cleaning. Wafer-level packaging addresses compact chip connections, while the Syndion etch family focuses on precise removal deep into silicon. These are concrete opportunities, not evidence of separately reported product growth.

Operating margin measures the share of revenue remaining after operating costs. In the June-ended fiscal fourth quarter, it widened against the same fiscal quarter of the prior year and the preceding fiscal quarter. Operating profit therefore grew faster than revenue against those periods.

That result does not establish pricing power by itself. Lam’s annual risk disclosures identify selling prices, customer mix and product mix as influences on results. Its patents, licenses and confidential process knowledge help protect its technology, but competitors can still challenge it with better products.

Reported diluted earnings per share increased in the June-ended fiscal fourth quarter against the same fiscal quarter of the prior year and the preceding fiscal quarter. This measure divides earnings attributable to shareholders across the diluted average share count.

Other non-operating income was modest relative to operating income in the reported quarter. The earnings analysis uses Massive’s reported consolidated figures, not an adjusted earnings measure. The available evidence does not isolate the contribution of repurchases to per-share growth.

For the reported June-ended fiscal fourth quarter, operating cash flow remained positive after gross cash purchases of property, plant and equipment. However, both operating cash flow and cash remaining after those purchases declined against the same fiscal quarter of the prior year.

For the trailing annual period ended at the June fiscal year-end, operating cash flow also covered gross cash equipment and property purchases. The displayed remainder is a derived measure, not issuer-defined free cash flow. It excludes asset-sale proceeds, intangible investments, leases and noncash commitments.

The annual filing reports lower operating cash flow for the fiscal year ended in June than for the preceding fiscal year. It also attributes higher net investing outflows against that preceding fiscal year primarily to capital expenditures supporting American laboratories and manufacturing facilities globally.

At the June fiscal year-end, cash and equivalents exceeded the combined reported current borrowings and noncurrent debt and capital lease obligations. This provides financial flexibility, although those borrowing categories do not represent every liability.

For the fiscal year ended in June, financing cash outflows increased against the preceding fiscal year. The annual filing attributes that change primarily to greater share repurchases, repayment of maturing senior notes and higher dividend payments associated with a higher dividend rate. These uses of cash must be balanced with laboratory and manufacturing investment.

The current analyst targets and SPY comparison are shown in Our verdict.

Watch whether stronger sales continue to support operating profitability and whether operating cash flow follows reported earnings more closely. Matching fiscal periods matters because the quarter and the full fiscal year both showed weaker operating cash flow against their respective prior-year periods.

Execution also matters outside the financial statements. Laboratory investment, manufacturing capacity and new process technologies need to support dependable customer deliveries. Supplier delays, memory-customer spending decisions and greater purchasing power among consolidated chipmakers are material risks.